Information Provided By:
Fly News Breaks for October 17, 2018
KLAC, AMAT, LRCX
Oct 17, 2018 | 07:33 EDT
Stifel analyst Patrick Ho believes Lam Research's (LRCX) earnings call allayed many of the concerns that the industry could be heading for an extended downturn and thinks Lam shares and the group overall may experience a "relief rally" through this earnings season. Management reiterated its view that the September quarter would be a trough in 2018 and the December quarter was projected to be up, noted Ho, who believes this outlook is "credible" given Lam management's track record of setting proper expectations. However, Ho noted his estimates were too high entering the call and he has lowered his price target on Lam shares to $229 from $279 to reflect his new, reduced estimates. He keeps a Buy rating on Lam Research, whose peers Applied Materials (AMAT) and KLA-Tencor (KLAC).
News For LRCX;AMAT;KLAC From the Last 2 Days
KLAC
Apr 25, 2024 | 17:21 EDT
Check out this evening's top movers from around Wall Street, compiled by The Fly. HIGHER AFTER EARNINGSSnap (SNAP) up... To see the rest of the story go to thefly.com. See Story Here
KLAC
Apr 25, 2024 | 16:15 EDT
Reports Q3 revenue $2.36B, consensus $2.31B. "KLA's March quarter results were above our adjusted guidance as customer demand and company execution tracked consistent with our expectations," said Rick Wallace, president and CEO, KLA Corporation. "As we have highlighted over the past few quarters, market conditions have stabilized and we expect our business levels to improve as we progress through the year. We are encouraged by the improvement in our customers' businesses across multiple end markets and this improvement is translating into constructive discussions with our customers about future opportunities for leading edge capacity investments."
LRCX
Apr 25, 2024 | 07:29 EDT
BofA analyst Vivek Arya raised the firm's price target on Lam Research to $1,000 from $970 and keeps a Buy rating on the shares. Lam "delivered a solid beat and raise" with growth expected to accelerate into the second half of the calendar year, says the firm, which adds that it is "beginning to see the green shoots of NAND recovery."
LRCX
Apr 25, 2024 | 07:27 EDT
TD Cowen raised the firm's price target on Lam Research to $1,000 from $975 and keeps a Buy rating on the shares. The firm said NAND recovery is off to a good start with two consecutive quarters of 25-30% sequential growth and other vectors are also showing growth.
LRCX
Apr 25, 2024 | 06:51 EDT
Susquehanna analyst Mehdi Hosseini lowered the firm's price target on Lam Research to $850 from $880 and keeps a Neutral rating on the shares. The firm said they posted a good print and guidance as its report and commentary were inline with Susquehanna's preview.
LRCX
Apr 24, 2024 | 18:48 EDT
Check out this evening's top movers from around Wall Street, compiled by The Fly. HIGHER AFTER EARNINGSImpinj (PI) up... To see the rest of the story go to thefly.com. See Story Here
LRCX
Apr 24, 2024 | 14:19 EDT
Notable companies reporting after the market close, with earnings consensus, include Meta Plataforms (META), consensus $4.32... IBM (IBM), consensus $1.60... ServiceNow (NOW), consensus $3.14... Lam Research (LRCX), consensus $7.30... Chipotle Mexican Grill (CMG), consensus $11.68... O'Reilly Automotive (ORLY), consensus $9.26... Ford Motor (F), consensus 42c... United Rentals (URI), consensus $8.32... Align Technology (ALGN), consensus $1.97... Molina Healthcare (MOH), consensus $5.59... Teradyne (TER), consensus 33c... Universa Health Services (UHS), consensus $3.16... Western Union (WU), consensus 41c.